Please login to the form below

Not currently logged in

Jeff Jonker joins Theravance

He has experience at Genentech
Theravance Jeff Jonker

Theravance has appointed Jeff Jonker as senior VP, corporate and business development.

He joins the US-based biopharma from Satori where he served as chief business officer.

In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company's business and corporate development affairs.

Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.

"Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.

The CEO also commented that Jonkers' appointment will support the companys' plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.

“As Theravance separates into two companies, Jeff's track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.

4th November 2013

From: Research, Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...